Prospective Subunit Nanovaccine against

Humans Aged, 80 and over Mycobacterium tuberculosis Cord Factors / pharmacology Prospective Studies Tuberculosis / drug therapy Cytokines
Mycobacterium tuberculosis (H37Rv) cord factor trehalose 6,6′ dimycolate (TDM) cubosomes immune response nanovaccine

Journal

ACS applied materials & interfaces
ISSN: 1944-8252
Titre abrégé: ACS Appl Mater Interfaces
Pays: United States
ID NLM: 101504991

Informations de publication

Date de publication:
14 Jun 2023
Historique:
medline: 16 6 2023
pubmed: 1 6 2023
entrez: 1 6 2023
Statut: ppublish

Résumé

An improved vaccine is urgently needed to replace the now more than 100-year-old Bacillus Calmette-Guérin (BCG) vaccine against tuberculosis (TB) disease, which represents a significant burden on global public health. Mycolic acid, or cord factor trehalose 6,6' dimycolate (TDM), a lipid component abundant in the cell wall of the pathogen

Identifiants

DOI: 10.1021/acsami.3c04063 PMID: 37262346
pubmed: 37262346
doi: 10.1021/acsami.3c04063
doi:

Substances chimiques

Cord Factors 0
Cytokines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

27670-27686

Auteurs

Sampa Sarkar (S)

School of Science, STEM College, RMIT University, Melbourne 3001, Victoria, Australia.
ORCID: 0000-0003-3265-4546

Abhishek Mishra (A)

Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, Texas 77030, United States.

Selvakannan Periasamy (S)

School of Science, STEM College, RMIT University, Melbourne 3001, Victoria, Australia.
ORCID: 0000-0001-5859-8226

Brendan Dyett (B)

School of Science, STEM College, RMIT University, Melbourne 3001, Victoria, Australia.
ORCID: 0000-0002-8417-2736

Prashant Dogra (P)

Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, Texas 77030, United States.
Department of Physiology and Biophysics, Weill Cornell Medical College, New York, New York 10021, United States.

Andrew S Ball (AS)

School of Science, STEM College, RMIT University, Melbourne 3001, Victoria, Australia.

Leslie Y Yeo (LY)

School of Engineering, STEM College, RMIT University, Melbourne 3001, Victoria, Australia.
ORCID: 0000-0002-5949-9729

Jacinta F White (JF)

The Commonwealth Scientific and Industrial Research Organisation, Clayton 3169, Victoria, Australia.

Zhihui Wang (Z)

Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, Texas 77030, United States.
Department of Physiology and Biophysics, Weill Cornell Medical College, New York, New York 10021, United States.
Neal Cancer Center, Houston Methodist Research Institute, Houston, Texas 77030, United States.
ORCID: 0000-0001-6262-700X

Vittorio Cristini (V)

Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, Texas 77030, United States.
Neal Cancer Center, Houston Methodist Research Institute, Houston, Texas 77030, United States.
Department of Imaging Physics, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, United States.
Physiology, Biophysics, and Systems Biology Program, Graduate School of Medical Sciences, Weill Cornell Medicine, New York, New York 10021, United States.

Chinnaswamy Jagannath (C)

Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, Texas 77030, United States.

Arshad Khan (A)

Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, Texas 77030, United States.

Sarvesh K Soni (SK)

School of Science, STEM College, RMIT University, Melbourne 3001, Victoria, Australia.

Calum J Drummond (CJ)

School of Science, STEM College, RMIT University, Melbourne 3001, Victoria, Australia.
ORCID: 0000-0001-7340-8611

Charlotte E Conn (CE)

School of Science, STEM College, RMIT University, Melbourne 3001, Victoria, Australia.
ORCID: 0000-0002-3362-3453

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Prospective Subunit Nanovaccine against
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Sujet âgé de 80 ans ou plus › Prospective Subunit Nanovaccine against
questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Bâtonnets à Gram positif › Bâtonnets asporogènes à Gram positif › Bâtonnets asporogènes réguliers à Gram positif › Mycobacteriaceae › Mycobacterium › Mycobacterium tuberculosis › Prospective Subunit Nanovaccine against
questionsmedicales.fr › Facteurs biologiques › Toxines biologiques › Toxines bactériennes › Facteurs cord › Prospective Subunit Nanovaccine against
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études prospectives › Prospective Subunit Nanovaccine against
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram positif › Infections à Actinomycetales › Infections à Mycobacterium › Tuberculose › Prospective Subunit Nanovaccine against
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Prospective Subunit Nanovaccine against